PBI-004 - Novel broad-spectrum peptide therapy reverses respiratory infections with multidrug-resistant gram-negative bacteria.

MLA

Wannigama, D. L., et al. “PBI-004 - Novel Broad-Spectrum Peptide Therapy Reverses Respiratory Infections with Multidrug-Resistant Gram-Negative Bacteria.” International Journal of Antimicrobial Agents, vol. 58, Sept. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2021.106421.27.

APA

Wannigama, D. L., Hurst, C., Monk, P. N., Stick, S. M., Kicic, A., & Chatsuwan, T. (2021). PBI-004 - Novel broad-spectrum peptide therapy reverses respiratory infections with multidrug-resistant gram-negative bacteria. International Journal of Antimicrobial Agents, 58, N.PAG. https://doi.org/10.1016/j.ijantimicag.2021.106421.27

Chicago

Wannigama, D.L., C. Hurst, P.N. Monk, S.M. Stick, A. Kicic, and T. Chatsuwan. 2021. “PBI-004 - Novel Broad-Spectrum Peptide Therapy Reverses Respiratory Infections with Multidrug-Resistant Gram-Negative Bacteria.” International Journal of Antimicrobial Agents 58 (September): N.PAG. doi:10.1016/j.ijantimicag.2021.106421.27.